Quick Answer
CERO THERAPEUTICS HOLDINGS, INC. reported Net Income Loss of -$7.73 million for the year ending 2024.
- CERO THERAPEUTICS HOLDINGS, INC. showed a decrease of -1,251.3% in Net Income Loss from 2024 to 2024.
- This data is from CERO THERAPEUTICS HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2022 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2024), CERO THERAPEUTICS HOLDINGS, INC.'s Net Income Loss has declined by 1,058.0%.
- Historical annual values: Fiscal year 2024: -$7.73 million | Fiscal year 2024: -$572.2 thousand | Fiscal year 2023: -$7.29 million | Fiscal year 2022: -$667.7 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: